🔴 Nasus Pharma is trading 8% down today as 10-year Treasury yield hits 19-year high

Nasus Pharma is trading at $3.35, down 7.97%, amid broader risk-off pressure, though the sharper decline’s trigger remains unclear.

• No reliable Nasus Pharma-specific announcement dated September 24, 2026, was identified; recent coverage describes routine trading.
• The 10-year Treasury yield reached 5.14%, a 19-year high, as Nasdaq futures and major indexes declined.
• A recently disclosed $50 million ordinary-share offering may remain a dilution overhang, but available evidence does not directly link it to September 24 trading.